Business Wire

CA-ABZENA

Share
Abzena Announces 14-Month Cell Line to Phase 1 GMP Service and Appointment of Shahram Katousian as Head of Biologics Manufacturing

Abzena, the leading biotherapeutics target to GMP partner research organization (PRO) announced an accelerated program to IND. This reduces timeline from stable pool to GMP down to 14 months. The timeline is achieved by use of single project team with experienced leadership, overlapping of operational activities, internal technology transfer within Abzena, proprietary technologies and scalable single use bioreactors.

Abzena builds on a track record of 10 biotherapeutics currently in integrated IND phase of development or early clinical development. The service uses a license and royalty free proprietary CHO cell line and efficient ambr® 15 development, followed by ambr® 250 process development, scaling to Sartorius single use bioreactors of 2 L to 500 L scale, and next year in 2020 to 2000 L scale. The use of clone selection and ambr® technology during cell line development (CLD) reduces project timelines and allows for introduction of at-risk development steps. Risk can be further reduced by addition of Abzena’s proprietary developability assessment service.

Abzena also announced the appointment of Shahram Katousian, as Senior Director and Head of Manufacturing and MSAT in our Biologics GMP facility. He joins Abzena following positions of increasing seniority at Genentech, Amgen, Baxter and Nektar Therapeutics. He brings deep CMC and Regulatory knowledge of clinical and commercial phase manufacturing including late stage BLA enabling activities for commercialization. He received his BS from University of British Columbia and MBA from University of Phoenix.

Jonathan Goldman MD Abzena CEO added: “Patient focused drug development is critical for me personally and for Abzena as an organization. I am delighted to announce this innovation for patients and Shahram’s appointment. His leadership will ensure successful execution on complex programs”.

Shahram Katousian also stated: “I am glad to have joined a talented team at Abzena to bring my experience and help our clients advance their products to the clinic, and ultimately help patients with new therapies”.

About Abzena

Abzena provides the most complete set of solutions in integrated discovery to clinical phase biopharmaceutical and antibody drug conjugation manufacturing services in the biopharma industry. The company has a global presence to provide support to around the world, with facilities in the US and UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity organizations, headquartered in New York City. For more information, please see www.abzena.com .

Contact:

Abzena Sven Lee Chief Business Officer sven.lee@abzena.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Combined Shareholders’ Meeting of June 19, 2025: All Submitted Resolutions Were Adopted20.6.2025 07:00:00 CEST | Press release

The Combined Shareholders’ Meeting of Bureau Veritas (the "Company"), chaired by Mr. Laurent Mignon, Chairman of the Board of directors, was held today at the Company’s head office. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250619834393/en/ Hinda Gharbi, CEO Bureau Veritas All resolutions submitted to the Shareholders’ Meeting were adopted at a large majority, including: The approval of the statutory and consolidated financial statements for the financial year ending on December 31, 2024, and the approval of a dividend distribution of €0.90 per share to be paid in cash on July 3, 2025 (ex-date on July 1, 2025) on positions closed on July 2, 2025; The approval of a related-party agreement concerning the Company’s participation in Wendel’s share placement (acquisition by the Company of its own shares); The approval of the report on Corporate Officers’ compensation; The approval of fixed, variable and extraordinary compone

Hanshow Showcases Retail Media and Store Intelligence at 2025 CGF Global Summit19.6.2025 17:00:00 CEST | Press release

Hanshow, a global leader in digital retail solutions, underscored its leadership in AI, IoT, and Retail Media at the 2025 Global Summit of the Consumer Good Forum (CGF), held from June 11 to 13 at RAI Amsterdam. From an immersive ‘Future Store’ showcase in the I-Zone to moderating one of the Summit’s most anticipated panel discussions, Hanshow demonstrated how its integrated platform is driving the next wave of store transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250619798164/en/ Inside the Future Store: Hanshow’s Real-Time Innovation at I-Zone At Booth No.8 in the I-Zone, Hanshow presented an interactive showcase themed “Powering Your Future Store,” highlighting four core pillars of the future store: real-time pricing and shelf operations powered by ESLs; smart carts that enhance the shopping experience with autonomous navigation and seamless checkout; GenAI-enabled journeys offering contextual promotions an

Grid Dynamics to Unveil Robotic Inspection Solution at Automatica 202519.6.2025 15:15:00 CEST | Press release

Key Takeaways: At Automatica 2025, Grid Dynamics will present TPGen—an AI robotic solution developed in partnership with Wandelbots to automate industrial robotic workflows that involve complex programming. The new solution dramatically reduces programming time—transforming what typically takes weeks of manual robot programming and analysis into automated processes completed in minutes through automatic tool-path generation based on CAD models. TPGen is built on top of the Wandelbots NOVA platform which enables seamless integration with a broad range of robotic manipulators. Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (Grid Dynamics)—a leading provider of technology consulting, platform and product engineering, AI, and digital‑engagement services—today announced it will showcase its TPGen robotic solution at Automatica 2025, the world's leading event for smart automation and robotics taking place in Munich, Germany from June 24-27, 2025. The TPGen solution from Grid Dynamics, developed

Experian Accelerates Migration to AWS to Drive Innovation with Generative AI19.6.2025 15:00:00 CEST | Press release

Global data and technology leader expands its cloud footprint to enhance performance and reliability, using AWS analytics and AI capabilities to give financial organizations access to real-time intelligence Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced that Experian, a global data and technology company, is embarking on the next phase of its cloud migration and has selected AWS as its preferred cloud. By leveraging AWS’s advanced cloud capabilities, Experian can provide faster, more scalable solutions that empower clients with deeper insights and more secure data services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250619029263/en/ Experian's cloud first strategy, in partnership with AWS, accelerates innovation by enhancing performance, scalability, and reliability, while enabling the company to better serve its clients with innovative products and solutions. By migrating of

Greenland Resources Receives 30-Year Exploitation License for Molybdenum and Magnesium19.6.2025 14:52:00 CEST | Press release

Greenland Resources Inc. (Cboe CA: MOLY | FSE: M0LY) and its fully owned Greenlandic subsidiary Greenland Resources A/S (“Greenland Resources” or the “Company”) is pleased to announce that today the Greenland’s Minister for Business, Mineral Resources, Energy, Justice and Gender Equality, Naaja H. Nathanielsen, together with Dr. Ruben Shiffman, Chairman of the Board of Directors of Greenland Resources, signed a 30-year exploitation permit for molybdenum and magnesium for the Company’s Malmbjerg project in east Greenland (now defined as the Piiaaffik Høstakken). The Company can apply to extend the licence period up to 50-years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250619915614/en/ Naalakkersuisut's Minister for Business, Mineral Resources, Energy, Justice and Gender Equality, Naaja H. Nathanielsen, stated at the handover ceremony: "It is with great satisfaction that the Greenland Government can grant another exploit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye